About AVT
Browse Articles
Authors
Customer Services

Current Issue

Displaying 10 results:

Free
Correction

Correction: Monitoring of serum HBV RNA, HBcrAg, HBsAg and anti-HBc levels in patients during long-term nucleoside/nucleotide analogue therapy

Hao Liao, Yan Liu, Xiaodong Li, Jie Wang, Xiangmei Chen, Jun Zou, Qi Li, Lujie Liu, Jun Wang, Bixia Huang, Fengmin Lu, Dongping Xu

Antiviral Therapy 2019; 24:151


Letter

The impact of a successful treatment of HCV on glyco-metabolic control in diabetic patients

Carla Carnovale, Marta Gentili, Carlo Magni, Faizan Mazhar, Giulia Mosini, Emilio Clementi, Sonia Radice

Antiviral Therapy 2019; 24:147-149


Short communication

HSV susceptibility to acyclovir – genotypic and phenotypic characterization

Raksha Vikas, Suresha G Prabhu, Piya P Mudgal, Ujwal Shetty, Kavitha Karunakaran, Anitha Jagadesh, Amogh Auti, Rithu P Stansilaus, Sudheesh Nair, Govindakarnavar Arunkumar

Antiviral Therapy 2019; 24:141-145


Original article

Peginterferon alfa-2a (40 kD) stopping rules in chronic hepatitis B: a systematic review and meta-analysis of individual participant data

Vedran Pavlovic, Lei Yang, Henry Lik-Yuen Chan, Jinlin Hou, Harry L Janssen, Jia-Horng Kao, Pietro Lampertico, Cheng-Yuan Peng, Teerha Piratvisuth, Alexander J Thompson, Heiner Wedemeyer, Lai Wei, Cynthia Wat

Antiviral Therapy 2019; 24:133-140


Original article

Tenofovir plus hepatitis B immunoglobulin treatment resulted in a rapid HBV DNA load decline in high-risk pregnant women who missed the optimal time window of antiviral prophylaxis

Tianyan Chen, Jinfeng Liu, Qiang Yu, Naijuan Yao, Yuan Yang, Yuchao Wu, Danfeng Ren, Zhen Tian, Yingren Zhao, Jing Wang

Antiviral Therapy 2019; 24:125-131


Original article

Automated nucleic acid isolation methods for HDV viral load quantification can lead to viral load underestimation

Birgit Bremer, Olympia E Anastasiou, Sandra Ciesek, Heiner Wedemeyer

Antiviral Therapy 2019; 24:117-123


Original article

Monitoring of serum HBV RNA, HBcrAg, HBsAg and anti-HBc levels in patients during long-term nucleoside/nucleotide analogue therapy

Hao Liao, Yan Liu, Xiaodong Li, Jie Wang, Xiangmei Chen, Jun Zou, Qi Li, Lujie Liu, Jun Wang, Bixia Huang, Fengmin Lu, Dongping Xu

Antiviral Therapy 2019; 24:105-115


Original article

Efavirenz pharmacokinetics during pregnancy and infant washout

Regis Kreitchmann, Stein Schalkwijk, Brookie Best, Jiajia Wang, Angela Colbers, Alice Stek, David Shapiro, Tim Cressey, Mark Mirochnick, David Burger

Antiviral Therapy 2019; 24:95-103


Free
Original article

Association of serum total cholesterol with pegylated interferon-α treatment in HBeAg-positive chronic hepatitis B patients

Zhen Xun, Jin-Piao Lin, Can Liu, Jin-Lan Huang, Ye Shen, Si-Yi Xu, Wen-Nan Wu, Qi-Shui Ou

Antiviral Therapy 2019; 24:85-93


Original article

HBV reactivation during direct-acting antiviral therapy in hepatitis B and C coinfected patients undergoing haemodialysis

Jing Wang, Chunhua Hu, Yi Chen, Zhengwen Liu, Qiang Yu, Shujuan Yang, Jun Dong, Yuan Yang, Yuchao Wu, Danfeng Ren, Naijuan Yao, Dandan Guo, Zhen Tian, Yingren Zhao, Tianyan Chen, Yingli He, Jinfeng Liu

Antiviral Therapy 2019; 24:77-84


Copyright © 2019 Nucleus Holdings Ltd. Part of Nucleus Global.
Design and Technology by Nucleus Global
Company registration No. 321 0712 (England & Wales). Registered Office address: Admiral House 76-78 Old Street, London EC1V 9AZ.